ITS

A more powerful way to test skin sensitisation

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser

"Detailed Report” feature for SkinSens ITS

Following the successful SkinSens ITS release during the Society of Toxicology annual meeting 2017, we received plenty of positive feedback and valuable suggestions for additional features.

Skin Sensitization Application

Allergic contact dermatitis (aka., skin sensitization) accounts for 20% of all contact dermatitis cases and hence has an estimated annual cost up to $200 million. It is also a public health problem...

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Latest Tweets

Douglas Connect (5 days ago)
RT @barryhardy: Do want an exciting career journey for 2019? Help advance the development and application of #Safety #Assessment Products d…
Douglas Connect (2 weeks ago)
Some of our most powerful modern pharmaceuticals come from nature. However, we are still nowhere near making full u… https://t.co/xPbh8qgsFB
Douglas Connect (2 weeks ago)
RT @barryhardy: Collaborative Developments on new methods #Safety #assessment #toxicology #risk #healthcare #environment at the National Co…
Douglas Connect (3 weeks ago)
We are looking for a strategic marketing leader to join the DC team - looking for a strong and dedicated knowledge… https://t.co/RDtLzKs4bL
Douglas Connect (4 weeks ago)
Register now to the hands-on training on #InVitro flow systems & #FAIR data integration for #SafetyAssessment Early… https://t.co/Hhu0kmE3U2

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com